Trial intelligence / Profile preview

Phenotypic Drug Probes and Tacrolimus DDIs

NCT02576366Phase 4Completed

Sponsor
UZ Leuven
Start
Jun 2016
Primary completion
May 2017
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by UZ Leuven. Started Jun 2016; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT02576366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02576366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call